144 related articles for article (PubMed ID: 36565565)
1. [Off-label use of gabapentinoid drugs: is it necessary a deprescription strategy?].
Echeverría Gorriti A; Alzueta Istúriz N; García González P; Fernández González J; Sanz Álvarez L; Garjón Parra J
Gac Sanit; 2023; 37():102283. PubMed ID: 36565565
[TBL] [Abstract][Full Text] [Related]
2. A Clinical Overview of Off-label Use of Gabapentinoid Drugs.
Goodman CW; Brett AS
JAMA Intern Med; 2019 May; 179(5):695-701. PubMed ID: 30907944
[TBL] [Abstract][Full Text] [Related]
3. Trends in Gabapentin and Pregabalin Prescribing in a Tertiary Pediatric Medical Center.
Donado C; Nedeljkovic K; Wangnamthip S; Solodiuk JC; Bourgeois FT; Berde CB
Hosp Pediatr; 2021 Aug; 11(8):909-914. PubMed ID: 34257145
[TBL] [Abstract][Full Text] [Related]
4. Gabapentin and pregabalin: do the benefits outweigh the harms?
Morrison EE; Sandilands EA; Webb DJ
J R Coll Physicians Edinb; 2017 Dec; 47(4):310-313. PubMed ID: 29537399
[TBL] [Abstract][Full Text] [Related]
5. Gabapentinoid Dosing and Associated Toxicities in Patients With or Without Concomitant Opioids During Hospitalization.
Tu TG; Sadeghi S; Atayee R; Lee K
Am J Hosp Palliat Care; 2022 May; 39(5):530-534. PubMed ID: 34409886
[TBL] [Abstract][Full Text] [Related]
6. Concomitant Use of Gabapentinoids with Opioids Is Associated with Increased Mortality and Morbidity among Dialysis Patients.
Waddy SP; Becerra AZ; Ward JB; Chan KE; Fwu CW; Eggers PW; Abbott KC; Kimmel PL
Am J Nephrol; 2020; 51(6):424-432. PubMed ID: 32428902
[TBL] [Abstract][Full Text] [Related]
7. Gabapentinoid Use in Perioperative Care and Current Controversies.
Patel AS; Abrecht CR; Urman RD
Curr Pain Headache Rep; 2022 Feb; 26(2):139-144. PubMed ID: 35084656
[TBL] [Abstract][Full Text] [Related]
8. A Retrospective Analysis of Gabapentinoid and Opioids to Opioid Monotherapy for Pain Relief in Patients with Chronic Neck and Low Back Pain.
Knezevic NN; Aijaz T; Camacho-Ortega A; Candido KD
Pain Med; 2021 Aug; 22(8):1760-1766. PubMed ID: 33502505
[TBL] [Abstract][Full Text] [Related]
9. Pregabalin and gabapentin in non-opioid poisoning deaths.
Kriikku P; Ojanperä I
Forensic Sci Int; 2021 Jul; 324():110830. PubMed ID: 34000615
[TBL] [Abstract][Full Text] [Related]
10. Gabapentinoid and Opioid Utilization and Cost Trends Among Injured Workers.
Liu C; Lavin RA; Yuspeh L; Leung N; Kalia N; Tsourmas NF; Williams L; Bernacki EJ; Tao XG
J Occup Environ Med; 2021 Feb; 63(2):e46-e52. PubMed ID: 33196519
[TBL] [Abstract][Full Text] [Related]
11. Opioid and gabapentinoid prescriptions in England from 2015 to 2020.
Xia Y; Forget P
PLoS One; 2022; 17(11):e0276867. PubMed ID: 36441772
[TBL] [Abstract][Full Text] [Related]
12. Fatalities associated with gabapentinoids in England (2004-2020).
Kalk NJ; Chiu CT; Sadoughi R; Baho H; Williams BD; Taylor D; Copeland CS
Br J Clin Pharmacol; 2022 Aug; 88(8):3911-3917. PubMed ID: 35435281
[TBL] [Abstract][Full Text] [Related]
13. Co-prescription of gabapentinoids and opioids among adults with and without osteoarthritis in the United Kingdom between 1995 and 2017.
Yu D; Appleyard T; Cottrell E; Peat G
Rheumatology (Oxford); 2021 Apr; 60(4):1942-1950. PubMed ID: 33159800
[TBL] [Abstract][Full Text] [Related]
14. Trends in First Gabapentin and Pregabalin Prescriptions in Primary Care in the United Kingdom, 1993-2017.
Montastruc F; Loo SY; Renoux C
JAMA; 2018 Nov; 320(20):2149-2151. PubMed ID: 30480717
[TBL] [Abstract][Full Text] [Related]
15. Characterization of Outpatient Gabapentinoid Prescribing for Pain.
Banks C; A Bowman L; Merrey J; Waldfogel JM
J Pain Palliat Care Pharmacother; 2023 Jun; 37(2):143-147. PubMed ID: 36762999
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of and Factors Associated with Gabapentinoid Use and Misuse Among Texas Medicaid Recipients.
Ibiloye EA; Barner JC; Lawson KA; Rascati KL; Evoy KE; Peckham AM
Clin Drug Investig; 2021 Mar; 41(3):245-253. PubMed ID: 33580482
[TBL] [Abstract][Full Text] [Related]
17. Trends in gabapentinoid prescribing, co-prescribing of opioids and benzodiazepines, and associated deaths in Scotland.
Torrance N; Veluchamy A; Zhou Y; Fletcher EH; Moir E; Hebert HL; Donnan PT; Watson J; Colvin LA; Smith BH
Br J Anaesth; 2020 Aug; 125(2):159-167. PubMed ID: 32571568
[TBL] [Abstract][Full Text] [Related]
18. Risk of respiratory depression with opioids and concomitant gabapentinoids.
Savelloni J; Gunter H; Lee KC; Hsu C; Yi C; Edmonds KP; Furnish T; Atayee RS
J Pain Res; 2017; 10():2635-2641. PubMed ID: 29180889
[TBL] [Abstract][Full Text] [Related]
19. Trends in new prescription of gabapentinoids and of coprescription with opioids in the 4 nations of the UK, 1993-2017.
Rahman A; Kane J; Montastruc F; Renoux C
Br J Clin Pharmacol; 2021 Aug; 87(8):3349-3353. PubMed ID: 33393673
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of Gabapentinoids and Central Nervous System Depressant Drugs, and Their Association with Risk Factors for Respiratory Depression in Primary Care Patients.
Fernández-Liz E; Barceló-Colomer ME; Gómez-Ganda L; Varon-Galcera C; Lalueza-Broto P; Medel-Rebollo FJ; Hortelano-García MA; Martín-Gracia E
Clin Drug Investig; 2022 May; 42(5):417-426. PubMed ID: 35446006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
